Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis.
Primary Sjögren's syndrome related optic neuritis.
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis.
Increase in the iron content of the substantia nigra and red nucleus in multiple sclerosis and clinically isolated syndrome: A 7 Tesla MRI study.
Validity and test-retest reliability of a measure of hand sensibility and manual dexterity in people with multiple sclerosis: the ReSense test.
Persistence and pathogenesis of the neurotropic polyomavirus JC.
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.
Elevated Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort.
Visual pathway neurodegeneration winged by mitochondrial dysfunction.
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Deep breathing exercises with positive expiratory pressure in patients with multiple sclerosis - a randomized controlled trial.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Restless legs syndrome in Iranian patients with multiple sclerosis.
Genomic Characterization of Japanese Macaque Rhadinovirus: A Novel Herpesvirus Isolated from a Nonhuman Primate with a Spontaneous Inflammatory Demyelinating Disease.
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Epigenetic changes in inflammatory and autoimmune diseases.
Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?
Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.
Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?
Goodbye to all that: a short history of CCSVI.
Th17 cells in central nervous system autoimmunity.
Oral versus intravenous steroids in multiple sclerosis relapses - a perennial question?
Human vaccines & immunotherapeutics: news.
IL1-β expression in multiple sclerosis.
Pages
« first
‹ previous
…
442
443
444
445
446
447
448
449
450
…
next ›
last »